These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38007645)

  • 1. Proteome Network Analysis Identifies Potential Biomarkers for Brain Aging.
    Short MI; Fohner AE; Skjellegrind HK; Beiser A; Gonzales MM; Satizabal CL; Austin TR; Longstreth WT; Bis JC; Lopez O; Hveem K; Selbæk G; Larson MG; Yang Q; Aparicio HJ; McGrath ER; Gerszten RE; DeCarli CS; Psaty BM; Vasan RS; Zare H; Seshadri S
    J Alzheimers Dis; 2023; 96(4):1767-1780. PubMed ID: 38007645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Plasma YKL-40 With MRI, CSF, and Cognitive Markers of Brain Health and Dementia.
    Pase MP; Himali JJ; Puerta R; Beiser AS; Gonzales MM; Satizabal CL; Yang Q; Aparicio HJ; Kojis DJ; Decarli CS; Lopez OL; Longstreth W; Gudnason V; Mosley TH; Bis JC; Fohner A; Psaty BM; Boada M; García-González P; Valero S; Marquié M; Tracy R; Launer LJ; Ruiz A; Fornage M; Seshadri S
    Neurology; 2024 Feb; 102(4):e208075. PubMed ID: 38290090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between inflammatory biomarkers and cognitive aging.
    Fang Y; Doyle MF; Chen J; Alosco ML; Mez J; Satizabal CL; Qiu WQ; Murabito JM; Lunetta KL
    PLoS One; 2022; 17(9):e0274350. PubMed ID: 36083988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma EFEMP1 Is Associated with Brain Aging and Dementia: The Framingham Heart Study.
    McGrath ER; Himali JJ; Levy D; Yang Q; DeCarli CS; Courchesne P; Satizabal CL; Finney R; Vasan RS; Beiser AS; Seshadri S
    J Alzheimers Dis; 2022; 85(4):1657-1666. PubMed ID: 34958018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Serum Vitamin D with the Risk of Incident Dementia and Subclinical Indices of Brain Aging: The Framingham Heart Study.
    Karakis I; Pase MP; Beiser A; Booth SL; Jacques PF; Rogers G; DeCarli C; Vasan RS; Wang TJ; Himali JJ; Annweiler C; Seshadri S
    J Alzheimers Dis; 2016; 51(2):451-61. PubMed ID: 26890771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
    Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging.
    Lieb W; Beiser AS; Vasan RS; Tan ZS; Au R; Harris TB; Roubenoff R; Auerbach S; DeCarli C; Wolf PA; Seshadri S
    JAMA; 2009 Dec; 302(23):2565-72. PubMed ID: 20009056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of CD14 with incident dementia and markers of brain aging and injury.
    Pase MP; Himali JJ; Beiser AS; DeCarli C; McGrath ER; Satizabal CL; Aparicio HJ; Adams HHH; Reiner AP; Longstreth WT; Fornage M; Tracy RP; Lopez O; Psaty BM; Levy D; Seshadri S; Bis JC
    Neurology; 2020 Jan; 94(3):e254-e266. PubMed ID: 31818907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter hyperintensities and imaging patterns of brain ageing in the general population.
    Habes M; Erus G; Toledo JB; Zhang T; Bryan N; Launer LJ; Rosseel Y; Janowitz D; Doshi J; Van der Auwera S; von Sarnowski B; Hegenscheid K; Hosten N; Homuth G; Völzke H; Schminke U; Hoffmann W; Grabe HJ; Davatzikos C
    Brain; 2016 Apr; 139(Pt 4):1164-79. PubMed ID: 26912649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating ceramide ratios and risk of vascular brain aging and dementia.
    McGrath ER; Himali JJ; Xanthakis V; Duncan MS; Schaffer JE; Ory DS; Peterson LR; DeCarli C; Pase MP; Satizabal CL; Vasan RS; Beiser AS; Seshadri S
    Ann Clin Transl Neurol; 2020 Feb; 7(2):160-168. PubMed ID: 31950603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk.
    Walker KA; Chen J; Zhang J; Fornage M; Yang Y; Zhou L; Grams ME; Tin A; Daya N; Hoogeveen RC; Wu A; Sullivan KJ; Ganz P; Zeger SL; Gudmundsson EF; Emilsson V; Launer LJ; Jennings LL; Gudnason V; Chatterjee N; Gottesman RF; Mosley TH; Boerwinkle E; Ballantyne CM; Coresh J
    Nat Aging; 2021 May; 1(5):473-489. PubMed ID: 37118015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical Activity, Brain Volume, and Dementia Risk: The Framingham Study.
    Tan ZS; Spartano NL; Beiser AS; DeCarli C; Auerbach SH; Vasan RS; Seshadri S
    J Gerontol A Biol Sci Med Sci; 2017 Jun; 72(6):789-795. PubMed ID: 27422439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphometric network differences in ageing versus Alzheimer's disease dementia.
    Pichet Binette A; Gonneaud J; Vogel JW; La Joie R; Rosa-Neto P; Collins DL; Poirier J; Breitner JCS; Villeneuve S; Vachon-Presseau E; ;
    Brain; 2020 Feb; 143(2):635-649. PubMed ID: 32040564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth Differentiation Factor 15 and NT-proBNP as Blood-Based Markers of Vascular Brain Injury and Dementia.
    McGrath ER; Himali JJ; Levy D; Conner SC; DeCarli C; Pase MP; Ninomiya T; Ohara T; Courchesne P; Satizabal CL; Vasan RS; Beiser AS; Seshadri S
    J Am Heart Assoc; 2020 Oct; 9(19):e014659. PubMed ID: 32921207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proximity to dementia onset and multi-modal neuroimaging changes: The prevent-dementia study.
    Mak E; Dounavi ME; Low A; Carter SF; McKiernan E; Williams GB; Jones PS; Carriere I; Muniz GT; Ritchie K; Ritchie C; Su L; O'Brien JT
    Neuroimage; 2021 Apr; 229():117749. PubMed ID: 33454416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology characterization of Alzheimer's disease in South China's aging population: for the Greater-Bay-Area Healthy Aging Brain Study (GHABS).
    Liu Z; Shi D; Cai Y; Li A; Lan G; Sun P; Liu L; Zhu Y; Yang J; Zhou Y; Guo L; Zhang L; Deng S; Chen S; Yu X; Chen X; Zhao R; Wang Q; Ran P; Xu L; Zhou L; Sun K; Wang X; Peng Q; Han Y; Guo T
    Alzheimers Res Ther; 2024 Apr; 16(1):84. PubMed ID: 38627753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study.
    Hilal S; Wolters FJ; Verbeek MM; Vanderstichele H; Ikram MK; Stoops E; Ikram MA; Vernooij MW
    Alzheimers Res Ther; 2018 Jun; 10(1):63. PubMed ID: 29960604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Particulate matter and episodic memory decline mediated by early neuroanatomic biomarkers of Alzheimer's disease.
    Younan D; Petkus AJ; Widaman KF; Wang X; Casanova R; Espeland MA; Gatz M; Henderson VW; Manson JE; Rapp SR; Sachs BC; Serre ML; Gaussoin SA; Barnard R; Saldana S; Vizuete W; Beavers DP; Salinas JA; Chui HC; Resnick SM; Shumaker SA; Chen JC
    Brain; 2020 Jan; 143(1):289-302. PubMed ID: 31746986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.